EUVIMEDEUVIMED entdecken
Crossref

Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data

Ben Li, Rakan Nassereldine, Abdelrahman Zamzam, Muzammil H Syed, Muhammad Mamdani, Mohammed Al-Omran, Rawand Abdin, Mohammad Qadura

Journal of Vascular Surgery · 2024

DOI: 10.1016/j.jvs.2024.03.450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Ben Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, U…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Biomarkers, Predictive Value of Tests, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Prognostic tools for individuals with peripheral artery disease (PAD) remain limited. We developed prediction models for 3-year PAD-related major adverse limb events (MALE) using demographic, clinical, and biomarker data previously validated by our group. METHODS: We performed a prognostic study using a prospectively recruited cohort of patients with PAD (n = 569). Demographic/clinical data were recorded including sex, age, comorbidities, previous procedures, and medications. Plasma concentrations of three biomarkers (N-terminal pro-B-type natriuretic peptide [NT-proBNP], fatty acid binding protein 3 [FABP3], and FABP4) were measured at baseline. The cohort was followed for 3 years. MALE was the primary outcome (composite of open/endovascular vascular intervention or major amputation). We trained three machine learning models with 10-fold cross-validation using demographic, clinical, and biomarker data (random forest, decision trees, and Extreme Gradient Boosting [XGBoost]) to predict 3-year MALE in patients. Area under the receiver operating characteristic curve (AUROC) was the primary model evaluation metric. RESULTS: Three-year MALE was observed in 162 patients (29%). XGBoost was the top-performing predictive model for 3-year MALE, achieving the following performance metrics: AUROC = 0.88 (95% confidence interval [CI], 0.84-0.94); sensitivity, 88%; specificity, 84%; positive predictive value, 83%; and negative predictive value, 91% on test set data. On an independent validation cohort of patients with PAD, XGBoost attained an AUROC of 0.87 (95% CI, 0.82-0.90). The 10 most important predictors of 3-year MALE consisted of: (1) FABP3; (2) FABP4; (3) age; (4) NT-proBNP; (5) active smoking; (6) diabetes; (7) hypertension; (8) dyslipidemia; (9) coronary artery disease; and (10) sex. CONCLUSIONS: We built robust machine learning algorithms that accurately predict 3-year MALE in patients with PAD using demographic, clinical, and novel biomarker data. Our algorithms can support risk stratification of patients with PAD for additional vascular evaluation and early aggressive medical management, thereby improving outcomes. Further validation of our models for clinical implementation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseBiomarkersPredictive Value of TestsNatriuretic Peptide, BrainPeptide FragmentsFatty Acid Binding Protein 3Fatty Acid-Binding ProteinsAmputation, SurgicalHumansMaleAgedRisk AssessmentRisk FactorsFemaleProspective StudiesMiddle AgedTime FactorsDecision Support TechniquesMachine LearningVascular Surgical ProceduresEndovascular ProceduresLimb SalvageReproducibility of ResultsAged, 80 and over

Stichwörter der Autor:innen

BiomarkersMajor adverse limb eventPeripheral artery diseasePrognosis

Substanzen

BiomarkersNatriuretic Peptide, BrainPeptide FragmentsFatty Acid Binding Protein 3Fatty Acid-Binding Proteinspro-brain natriuretic peptide (1-76)FABP3 protein, humanFABP4 protein, human

Autor:innen und Institutionen

  • Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada; Institute of Medical S…
  • Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
  • Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM), University of Toronto, Toronto, Ontario, Canada; D…
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Zitieren

APA

Li, B., Nassereldine, R., Zamzam, A., Syed, M. H., Mamdani, M., Al-Omran, M., Abdin, R., & Qadura, M. (2024). Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.03.450

Vancouver

Li B, Nassereldine R, Zamzam A, Syed MH, Mamdani M, Al-Omran M, et al. Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.03.450

BibTeX
@article{Li2024,
  author = {Li, Ben and Nassereldine, Rakan and Zamzam, Abdelrahman and Syed, Muzammil H and Mamdani, Muhammad and Al-Omran, Mohammed and Abdin, Rawand and Qadura, Mohammad},
  title = {Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  doi = {10.1016/j.jvs.2024.03.450}
}
Kostenlos starten →